Agenus maintains a global footprint by collaborations and partnerships with foremost pharmaceutical and biotechnology providers in North The united states, Europe and Asia. Its agreements incorporate exploration and progress collaborations, license preparations and co-growth plans targeted at accelerating the interpretation of novel immunotherapies